Molecular Biomarkers for the Evaluation of Colorectal Cancer
作者： Antonia R. Sepulveda , Stanley R. Hamilton , Carmen J. Allegra , Wayne Grody , Allison M. Cushman-Vokoun
DOI: 10.1093/AJCP/AQW209
关键词:
摘要:
oup.com
elsevier.com
sci-hub.se 参考文章(142)
Tolia M, Tsoukalas N, Kostakis Id, Ardavanis A, Tzovaras Aa, Papakostidi A, Pistamaltzian N, Meta-analysis of the predictive value of KRAS mutations in treatment response using cetuximab in colorectal cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. ,vol. 17, pp. 73- ,(2012)
Jennifer S Lin, Elizabeth M Webber, Caitlyn A Senger, Rebecca S Holmes, Evelyn P Whitlock, Systematic review of pharmacogenetic testing for predicting clinical benefit to anti-EGFR therapy in metastatic colorectal cancer American Journal of Cancer Research. ,vol. 1, pp. 650- 662 ,(2011)
William K. Funkhouser, Ira M. Lubin, Federico A. Monzon, Barbara A. Zehnbauer, James P. Evans, Shuji Ogino, Jan A. Nowak, Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. The Journal of Molecular Diagnostics. ,vol. 14, pp. 91- 103 ,(2012) , 10.1016/J.JMOLDX.2011.11.001
Michelle Mancher, Dianne Miller Wolman, Sheldon Greenfield, Robin Graham, Earl Steinberg, Clinical Practice Guidelines We Can Trust ,(2013)
Wilbur A. Franklin, Jerry Haney, Michio Sugita, Lynne Bemis, Antonio Jimeno, Wells A. Messersmith, KRAS Mutation The Journal of Molecular Diagnostics. ,vol. 12, pp. 43- 50 ,(2010) , 10.2353/JMOLDX.2010.080131
S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, M.R. Stratton, The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics. ,vol. 57, ,(2008) , 10.1002/0471142905.HG1011S57
Zu‐Yao Yang, Xin‐Yin Wu, Ya‐Fang Huang, Meng‐Yang Di, Da‐Yong Zheng, Jin‐Zhang Chen, Hong Ding, Chen Mao, Jin‐Ling Tang, None, Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis. International Journal of Cancer. ,vol. 133, pp. 1914- 1925 ,(2013) , 10.1002/IJC.28153
Qi Xu, An Tao Xu, Ming Ming Zhu, Jin Lu Tong, Xi Tao Xu, Zhi Hua Ran, Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a meta-analysis. Journal of Digestive Diseases. ,vol. 14, pp. 409- 416 ,(2013) , 10.1111/1751-2980.12063
Mine S Cicek, Noralane M Lindor, Steven Gallinger, Bharati Bapat, John L Hopper, Mark A Jenkins, Joanne Young, Daniel Buchanan, Michael D Walsh, Loic Le Marchand, Terrilea Burnett, Polly A Newcomb, William M Grady, Robert W Haile, Graham Casey, Sarah J Plummer, Lisa A Krumroy, John A Baron, Stephen N Thibodeau, None, Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors: Results from the Colon Cancer Family Registry The Journal of Molecular Diagnostics. ,vol. 13, pp. 271- 281 ,(2011) , 10.1016/J.JMOLDX.2010.12.004
Kazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, Azusa Yoneshige, Akihiko Ito, Yosuke Togashi, Marco A. De Velasco, Masato Terashima, Yoshihiko Fujita, Shuta Tomida, Takao Tamura, Kazuhiko Nakagawa, Kazuto Nishio, Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0121891